Zhao et al. 70 identified IRS1 and IRS2 as inhibitory targets of miR-570 and verified that miR-570 is downregulated in CML clinical samples and in the K562 and LAMA-84 CML cell lines. This evidence concerns the gene IRS2 and chronic myelogenous leukemia, BCR-ABL1 positive.